Home
Alphamab Co. Ltd

Alphamab Co. Ltd Market Share Analysis for May 2026

Health > Biotechnology and Pharmaceuticals

Domainalphamab.com

Year Founded2009

Employees51 - 200

Annual Revenue--

Alphamab Co. Ltd

Alphamab Co. Ltd (including company regionals)

alphamab.com

See more website traffic and engagement information

Total visits to Alphamab Co. Ltd's top domains

Understand Alphamab Co. Ltd market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

alphamab.com1.9K

See more with Sales Intelligence

Avg. visit duration in Alphamab Co. Ltd's top domains

Analyze Alphamab Co. Ltd engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

alphamab.com00:00:55

See more with Sales Intelligence

Avg. pageviews on Alphamab Co. Ltd's top domains

See how Alphamab Co. Ltd keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

alphamab.com2.19

See more with Sales Intelligence

Alphamab Co. Ltd top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Alphamab Co. Ltd

These are the website technologies, by industry, used by Alphamab Co. Ltd top domains

Advertising (1)

PubMatic

eCommerce (1)

USPS

Email Services (1)

QQ Mail

Multilingual (1)

Multilingual Support

More Technologies

1

See all

News & Signals from Alphamab Co. Ltd

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAlphamab went public on Nov 30th '19.HONG KONG (Reuters) - Chinese biopharmaceutical company, Alphamab Oncology, plans to seek listing approval early next month for a Hong Kong initial public offering (IPO) of up to $350 million, people with direct knowledge of the matter said.

NewsAlphamab received financing of $130M in Series A on May 30th '18.Last year, Alphamab Oncology raised $130 million in a Series A funding round from investors such as Advantech Capital, PAG, China Venture Capital Fund, OrbiMed, Heritage Provider Network and Janchor Partners.